Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Maybe PYC will be to answer that in the next six months or so by which time their wont be much money left in the pot, Might just be enough for Suzy to order a pizza from deliveroo now i hope your not to disappointed iceman
Th Suzy has stated, R&D expenditure during this period will increase to cover the initial evaluation costs and support programmes, More cash needed fella
PM every thing you state is hypothetical or do you have inside information
1 )So the new Board have spent 2.4 million in the first year that equates to 600k a quarter ouch
2) Physiomics PLC to enable the systematic analysis of ValiRx's clinical results because suzy cant
3) ValiRx has made excellent progress in realigning its strategy and consolidating the position of all key projects. We also achieved a major milestone with the close out and reporting of the VAL201 Phase I/II clinical trial, demonstrating good safety and tolerability and early indications of efficacy. not true that was down to the old BOD
4) I believe the new strategy will deliver long term growth and value creation for shareholders, but we are only at the beginning of this journey. What a statement Kevin
Occam's razor tells me if you go to her with a fever and a cough she would tell you you have a cold
like I said she can’t read the trial data and you know it and Grace give it a rest your like a puppet
Yeah isn’t it true we have been waiting a year for peer review only Suzy isn’t qualified to read the data that’s why it’s gone to pyc that’s why the board can’t give us any updates on 201 no updates on 301 or 401 either so where are coms now
Know one can blame Suzy directly even though she has was on the payroll for many years but fair point even though she was sitting on the side lines
And of course it relevant because they have had done nothing with any or this good data for 12 month and counting I do wonder how long they will sit on there hands or have they just got to rely on other companies to read this data for them
Well it looks like multiple news due over the next 3 months
1) KTH222 is external and out of Valirx hands there not even involved with the grants
2) Val 301 is external and out of Valirx hands Japanese company can take as long as they like, and Valirx just have to wait
3) Val 201 is external and out of Valirx hands
4) Val 401 is external and out of Valirx hands
Can every one see a pattern Given our M/Cap and all trials external looks like Valirx is now a SITTING DUCK with a M/CAP DECREASING EVERY DAY
What a joke this has become